【摘 要】
:
AIM: To evaluate cladribine [2-chlorodeoxyadenosine (2-CdA)] therapy in refractory celiac disease (RCD) Ⅱ. METHODS: An open-label cohort-study of RCD Ⅱ patien
【机 构】
:
Department of Gastroenterology and Hepatology, VU University Medical Center,Department of Gastroente
【出 处】
:
World Journal of Gastroenterology